Deep Dive: The #MHRA is on a mission to cement the UK as a powerhouse for #clinicalresearch, starting with sweeping changes to clinical trial regulations. But what does this mean for R&D in the nation?
buff.ly/rm8HqBJ
@editorialeye.bsky.social
Web editor at pharmaphorum, keenly wordsmithing on and for the pharmaceutical and healthcare space.
Deep Dive: The #MHRA is on a mission to cement the UK as a powerhouse for #clinicalresearch, starting with sweeping changes to clinical trial regulations. But what does this mean for R&D in the nation?
buff.ly/rm8HqBJ
At #Anthropy25, @pharmaphorum.bsky.social sat down with Dr Sebastian Vaughan, CEO of #PhytomeLifeSciences, for a conversation on #mentalhealth, following the #AdelphiGroup sponsored panel, βRevolutionary Thinking for Mental Healthβ.
pharmaphorum.com/patients/con...
An ominous shadow falls over mRNA technology | Opinion
https://www.ft.com/content/70654d6d-48ad-45be-8a10-dcd1a75ffc5e
From prolonged timelines for #HealthTechnologyAssessments to disparities in #access between wealthier and less affluent nations in #Europe - Paolo Correale provides an overview of the current landscape and impact on #patientaccess.
#pricing #reimbursement #EVERSANA
pharmaphorum.com/market-acces...
On 11th February, pharmaphorum was invited by #Curia to attend a #parliamentaryroundtable focussed on #womenshealth, held at the House of Commons and hosted in collaboration with Members of Parliament and leading #healthcare experts.
pharmaphorum.com/patients/sta...